Chung Shil Kwak

Title: Chung Shil Kwak: Innovator in Pharmaceutical Compositions

Introduction

Chung Shil Kwak is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic bone diseases. His innovative work has led to the development of a unique pharmaceutical composition that addresses critical health issues.

Latest Patents

Chung Shil Kwak holds 1 patent for his invention titled "Pharmaceutical compositions and preparations for treatment of metabolic bone disease." This patent focuses on a pharmaceutical composition designed to treat metabolic bone disease effectively. The composition includes calcitriol, which reduces the rate of spine fractures and increases bone density, and alendronate, a bone resorption inhibitor. The combination of these two active ingredients in an optimal mixing ratio aims to provide a synergistic therapeutic effect. Additionally, the composition is formulated to inhibit hypercalcemia and improve drug compliance, thus effectively preventing the occurrence of osteoporosis.

Career Highlights

Chung Shil Kwak is associated with Yuyu Industrial Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving treatment options for patients suffering from metabolic bone diseases.

Collaborations

Chung has collaborated with notable colleagues, including Sung An Kang and Kyung Hee Lee, who have contributed to his research and development efforts.

Conclusion

Chung Shil Kwak's contributions to pharmaceutical innovations demonstrate his dedication to enhancing healthcare solutions. His patented work in treating metabolic bone disease reflects a significant advancement in the field.